This book explores cutting-edge research and applications in the field of nanomedicines for cancer imaging, diagnosis, and therapy. It begins by highlighting the pivotal role of engineered silica-based nanoparticles in the precise delivery of anticancer drugs. The book further delves into the versatile utilization of metallic nanoparticles for hyperthermia and chemotherapy, showcasing their efficacy in combating cancer and reducing treatment-related discomfort. Additionally, it examines the applications of functionalized nanomaterials in the emerging field of cancer stem cell therapy and the use of radioactive nanoparticles for precise cancer diagnosis and therapy. The book also provides a thorough review of the potential of functionalized lipid-based nanoparticles for precision and targeted treatment. It discusses the roles of dendrimer-based nanomaterials, carbon-based nanomedicines, inorganic nanostructured materials, and polymeric nanomaterials in the realms of cancer diagnosis and personalized, targeted cancer therapies. Finally, the book delves into the commercial aspects of nanomedicines, addressing the challenges and future prospects of introducing these groundbreaking technologies to the forefront of cancer care.

Key Features:

• Provides a comprehensive overview of the latest advancements in nanomedicines for cancer diagnosis and therapy
• Emphasizes the pivotal role of engineered silica-based nanoparticles for precise anticancer drug delivery
• Explores the use of metallic nanoparticles for hyperthermia and chemotherapy
• Discusses radioactive nanoparticles for precise diagnosis and functionalized lipid-based nanoparticles for targeted treatment
• Addresses the commercial aspects of nanomedicines, offering insights into the challenges and future prospects of these innovative technologies in the field of cancer care

This book is an invaluable resource for researchers and scientists in the fields of nanomedicine, oncology, and drug delivery systems.

Manashjit Gogoi is a Faculty in the Department of Biomedical Engineering at North-Eastern Hill University (NEHU), Shillong, India. He holds a Ph.D. in Biomedical Engineering from IIT Bombay, an M.Tech. in Bioelectronics from Tezpur University, and a B.E. in Chemical Engineering from Gauhati University. His research focuses on nanomedicine, biosensors, microfluidics, point-of-care diagnostics, cancer drug delivery, and magnetic nanoparticle-based therapeutics. He has over a decade of academic and research experience. Dr. Gogoi has led and contributed to several externally funded projects supported by DBT, SERB, and ANRF. He has supervised multiple Ph.D. and postgraduate students and has published widely in reputed international journals, along with contributions to edited books and book chapters. He is a Chartered Engineer and a member of several professional societies and editorial boards. His work has been recognized through national awards, including MeitY TIDE 2.0 and ABLE-BEST.

Sanjukta Patra is a faculty in the Department of Medical Sciences and Technology at Indian Institute of Technology Madras. Prior to this she was at Department of Biosciences and Bioengineering at Indian Institute of Technology Guwahati. She has nearly two decades of academic and research experience. Her research interests include Diagnostics and Therapeutics, Enzyme and Microbial Technologies, Recombinant Biomolecule production for Healthcare applications. Dr. Sanjukta has led and contributed to several externally funded projects supported by DBT, ICMR, MEITY, CSIR, SERB, and ANRF. She also has consultancy projects to her credit. She has contributed and collaborated on several research and development projects, including biosensor development for tuberculosis, candida, malaria, whole cell biosensor for small molecule on various platforms. She has granted patents on technology development, publications in international peer reviewed journals, along with contributions to edited books, book chapters and conference proceedings.